EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress

Andrä Brunner, Qiuzhen Li, Samuele Fisicaro, Alexandros Kourtesakis, Johanna Viiliäinen, Henrik J Johansson, Vijaya Pandey, Adarsh K Mayank, Janne Lehtiö, James A Wohlschlegel, Charles Spruck, Juha K Rantala und 2 weitere

Molecular Cell · 2023-10 · 83 (20) · 3720-3739.e8

DOI: 10.1016/j.molcel.2023.07.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2023-10. Verfasst von Andrä Brunner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden. Electronic address: andra.brunner@ki.se. Hauptthemen laut MEDLINE: Fanconi Anemia, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, AstraZeneca i Göteborg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fanconi AnemiaNeoplasmsHumansCell SurvivalChromatinCyclin EDNA DamageDNA RepairDNA ReplicationFanconi Anemia Complementation Group D2 ProteinF-Box Proteins

Stichwörter der Autor:innen

CYCLIN EDNA damageFANCD2FBXL12Fanconi anemiaSCF ubiquitin ligasecancer vulnerabilityreplication stresstherapeutic target

Substanzen

ChromatinCyclin EFanconi Anemia Complementation Group D2 ProteinFANCD2 protein, humanFbxl12 protein, humanF-Box Proteins

Autor:innen und Institutionen

  • Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden. Electronic address: andra.brunner@ki.se.
  • Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Stockholms län, Sweden.
  • Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Solna 17165, Stockholms län, Sweden.
  • Department of Biological Chemistry, University of California, Los Angeles, Los Angeles 90095, CA, USA.
  • NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla 92037, CA, USA.
  • Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, South Yorkshire, UK; Misvik Biology, Turku 20520, Finland.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • AstraZeneca i Göteborg
  • Cancerfonden
  • Radiumhemmets Forskningsfonder
  • Fanconi Anemia Research Fund
  • Karolinska Institutet
  • Yorkshire Cancer Research

Zitieren

APA

Brunner, A., Li, Q., Fisicaro, S., Kourtesakis, A., Viiliäinen, J., Johansson, H. J., Pandey, V., Mayank, A. K., Lehtiö, J., Wohlschlegel, J. A., Spruck, C., Rantala, J. K., Orre, L. M., & Sangfelt, O. (2023). FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress. Molecular Cell, 83(20), 3720-3739.e8. https://doi.org/10.1016/j.molcel.2023.07.026

Vancouver

Brunner A, Li Q, Fisicaro S, Kourtesakis A, Viiliäinen J, Johansson HJ, et al. FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress. Molecular Cell. 2023;83(20):3720-3739.e8. doi:10.1016/j.molcel.2023.07.026

BibTeX
@article{Brunner2023,
  author = {Brunner, Andrä and Li, Qiuzhen and Fisicaro, Samuele and Kourtesakis, Alexandros and Viiliäinen, Johanna and Johansson, Henrik J and Pandey, Vijaya and Mayank, Adarsh K and Lehtiö, Janne and Wohlschlegel, James A and Spruck, Charles and Rantala, Juha K and Orre, Lukas M and Sangfelt, Olle},
  title = {FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress},
  journal = {Molecular Cell},
  year = {2023},
  volume = {83},
  number = {20},
  pages = {3720--3739.e8},
  doi = {10.1016/j.molcel.2023.07.026}
}
Kostenlos starten →